Bioharvest Sciences Inc. (BHST)
Every figure this model derived for BHST, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.
The figures, and where each came from
This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.
| Figure | Value | XBRL tag | As at |
|---|---|---|---|
| capex | 2,355,000 | PaymentsToAcquirePropertyPlantAndEquipment |
2025-12-31 |
| cash | 23,025,000 | CashAndCashEquivalentsAtCarryingValue |
2025-12-31 |
| current assets | 30,500,000 | AssetsCurrent |
2025-12-31 |
| current liabilities | 7,684,000 | LiabilitiesCurrent |
2025-12-31 |
| equity | 25,448,000 | StockholdersEquity |
2025-12-31 |
| interest expense | 0 | InterestPaid |
2024-12-31 |
| ocf | -7,226,000 | NetCashProvidedByUsedInOperatingActivities |
2025-12-31 |
| revenue | 34,508,000 | Revenues |
2025-12-31 |
| sbc | 601,000 | AllocatedShareBasedCompensationExpense |
2024-12-31 |
The ratios
The figures themselves rather than their scores — what somebody looking up BHST on one particular measure came for.
| Ratio | Value |
|---|---|
| cash operating margin | -9.71 |
| current ratio | 3.97 |
| current ratio reported | 3.97 |
| ev owner earnings | -2.62 |
| ev sales | 0.77 |
| fcf margin | -27.76 |
| operating margin | -16.16 |
| owner earnings margin | -29.51 |
| revenue growth | 37.0 |
| revenue growth per share | 37.0 |
| roic | -35.09 |
| rule of 40 | 20.85 |
| sbc pct revenue | 1.74 |
Everything else this filing tags
91 more elements from BHST's own XBRL that this model has no measure for, newest reading each, largest first. Nothing here is converted, added up or renamed — it is the filing's own element names and the filing's own numbers.
| Element | Newest | As of | Periods | Unit |
|---|---|---|---|---|
AdditionalPaidInCapital | 133,001,000 | 2025-12-31 | 4 | USD |
RetainedEarningsAccumulatedDeficit | -107,553,000 | 2025-12-31 | 4 | USD |
Assets | 47,665,000 | 2025-12-31 | 4 | USD |
LiabilitiesAndStockholdersEquity | 47,665,000 | 2025-12-31 | 4 | USD |
NetCashProvidedByUsedInFinancingActivities | 30,187,000 | 2025-12-31 | 4 | USD |
OperatingExpenses | 26,051,000 | 2025-12-31 | 4 | USD |
CashAndCashEquivalents | 23,025,000 | 2025-12-31 | 1 | USD |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | 23,025,000 | 2025-12-31 | 6 | USD |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | 20,596,000 | 2025-12-31 | 4 | USD |
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments | 20,527,000 | 2024-12-31 | 2 | USD |
GrossProfit | 20,476,000 | 2025-12-31 | 4 | USD |
WeightedAverageNumberOfSharesIssuedBasic | 18,411,153 | 2025-12-31 | 4 | shares |
ProceedsFromIssuanceOfCommonStock | 18,262,000 | 2025-12-31 | 4 | USD |
SharesOutstanding | 17,327,716 | 2024-12-31 | 3 | shares |
AssetsNoncurrent | 17,165,000 | 2025-12-31 | 4 | USD |
SellingExpense | 15,812,000 | 2025-12-31 | 4 | USD |
LiabilitiesNoncurrent | 14,533,000 | 2025-12-31 | 4 | USD |
CostOfRevenue | 14,032,000 | 2025-12-31 | 4 | USD |
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest | -12,913,000 | 2024-12-31 | 2 | USD |
ProceedsFromRepaymentsOfOtherDebt | 12,402,000 | 2025-12-31 | 4 | USD |
ProfitLoss | -11,135,000 | 2025-12-31 | 4 | USD |
NetIncomeLoss | -11,135,000 | 2025-12-31 | 4 | USD |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | -11,059,000 | 2025-12-31 | 4 | USD |
PropertyPlantAndEquipmentGross | 10,506,000 | 2025-12-31 | 6 | USD |
FinanceLeaseLiabilityNoncurrent | 10,130,000 | 2025-12-31 | 4 | USD |
RightofuseAssets | 8,406,000 | 2025-12-31 | 6 | USD |
OperatingLeaseRightOfUseAsset | 8,406,000 | 2025-12-31 | 4 | USD |
PropertyPlantAndEquipmentNet | 8,326,000 | 2025-12-31 | 4 | USD |
DebtConversionOriginalDebtAmount1 | 7,603,000 | 2025-12-31 | 4 | USD |
ProceedsFromWarrantExercises | 6,800,000 | 2025-12-31 | 2 | USD |
OperatingIncomeLoss | -5,575,000 | 2025-12-31 | 4 | USD |
InterestExpenseOnOtherFinancialLiabilities | 5,538,000 | 2025-12-31 | 4 | USD |
OtherNonoperatingExpense | 5,538,000 | 2025-12-31 | 4 | USD |
ResearchAndDevelopmentExpense | 5,312,000 | 2025-12-31 | 4 | USD |
GeneralAndAdministrativeExpense | 4,927,000 | 2025-12-31 | 4 | USD |
InventoryNet | 4,559,000 | 2025-12-31 | 4 | USD |
StockIssuedDuringPeriodValueNewIssues | 4,330,000 | 2024-12-31 | 1 | USD |
ConversionOfStockSharesConverted1 | 2,940,882 | 2024-12-31 | 2 | shares |
AccountsPayableCurrent | 2,627,000 | 2025-12-31 | 4 | USD |
NetCashProvidedByUsedInInvestingActivities | -2,365,000 | 2025-12-31 | 4 | USD |
StockIssuedDuringPeriodValueOther | 2,296,000 | 2024-12-31 | 1 | USD |
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | 2,180,000 | 2025-12-31 | 6 | USD |
AccountsPayableAndAccruedLiabilitiesCurrent | 2,173,000 | 2025-12-31 | 4 | USD |
OtherLiabilitiesNoncurrent | 1,983,000 | 2025-12-31 | 4 | USD |
AccountsReceivableNetCurrent | 1,981,000 | 2025-12-31 | 4 | USD |
DepreciationDepletionAndAmortization | 1,624,000 | 2025-12-31 | 4 | USD |
LeaseLiabilities | 1,405,000 | 2025-12-31 | 4 | USD |
RepaymentsOfOtherDebt | 1,382,000 | 2025-12-31 | 4 | USD |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | 1,330,000 | 2024-12-31 | 3 | USD |
OperatingLeaseRightOfUseAssetAmortizationExpense | 1,160,000 | 2025-12-31 | 4 | USD |
AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment | 1,040,000 | 2025-12-31 | 4 | USD |
NotesAndLoansReceivableNetCurrent | 935,000 | 2025-12-31 | 4 | USD |
ReclassificationsOfTemporaryToPermanentEquity | 934,000 | 2024-12-31 | 1 | USD |
IncreaseDecreaseInInventories | 904,000 | 2025-12-31 | 4 | USD |
IncreaseDecreaseInAccountsReceivable | 865,000 | 2025-12-31 | 4 | USD |
StockIssuedDuringPeriodSharesNewIssues | 603,904 | 2024-12-31 | 2 | shares |
StockGrantedDuringPeriodValueSharebasedCompensation | 601,000 | 2024-12-31 | 2 | USD |
EmployeeBenefitsAndShareBasedCompensationNoncash | 597,000 | 2025-12-31 | 4 | USD |
DeferredIncome | 492,000 | 2025-12-31 | 4 | USD |
IncreaseDecreaseInOtherAccruedLiabilities | 482,000 | 2025-12-31 | 4 | USD |
OtherLiabilitiesCurrent | 452,000 | 2025-12-31 | 4 | USD |
RestrictedCash | 433,000 | 2025-12-31 | 4 | USD |
DisposalsPropertyPlantAndEquipment | 431,000 | 2025-12-31 | 4 | USD |
IncreaseDecreaseInDeferredLiabilities | -415,000 | 2025-12-31 | 4 | USD |
StockIssuedDuringPeriodValueStockOptionsExercised | 408,000 | 2024-12-31 | 2 | USD |
AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets | 399,000 | 2025-12-31 | 4 | USD |
OtherSignificantNoncashTransactionValueOfConsiderationGiven1 | 399,000 | 2025-12-31 | 4 | USD |
AccruedLiabilitiesCurrent | 386,000 | 2025-12-31 | 4 | USD |
IncreaseDecreaseInOtherReceivables | 240,000 | 2025-12-31 | 4 | USD |
IncreaseDecreaseThroughOtherChangesRightofuseAssets | 228,000 | 2025-12-31 | 3 | USD |
ShortTermBorrowings | 149,000 | 2025-12-31 | 4 | USD |
StockIssuedDuringPeriodSharesStockOptionsExercised | 106,132 | 2024-12-31 | 2 | shares |
IncreaseDecreaseInRightofuseAssets | -85,000 | 2025-12-31 | 3 | USD |
IncomeTaxExpenseBenefit | -76,000 | 2025-12-31 | 4 | USD |
OtherNonoperatingIncome | 54,000 | 2025-12-31 | 4 | USD |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations | 39,000 | 2025-12-31 | 4 | USD |
IncomeTaxesPaidNet | 39,000 | 2025-12-31 | 2 | USD |
ProceedsFromStockOptionsExercised | 36,000 | 2025-12-31 | 2 | USD |
StockIssuedDuringPeriodValueIssuedForServices | 16,000 | 2023-12-31 | 1 | USD |
NumberOfOperatingSegments | 2 | 2024-12-31 | 1 | pure |
EarningsPerShareBasic | -1 | 2025-12-31 | 4 | USD/shares |
InterestIncomeOnOtherFinancialAssets | 0 | 2024-12-31 | 2 | USD |
InterestIncomeOnDeposits | 0 | 2024-12-31 | 1 | USD |
ProceedsFromIssuingOtherEquityInstruments | 0 | 2025-12-31 | 2 | USD |
AllowanceForDoubtfulAccountsReceivable | 0 | 2025-12-31 | 4 | USD |
ConvertibleDebtCurrent | 0 | 2024-12-31 | 2 | USD |
DeferredIncomeTaxExpenseBenefit | 0 | 2025-12-31 | 4 | USD |
DerivativeLiabilitiesCurrent | 0 | 2024-12-31 | 2 | USD |
OtherSignificantNoncashTransactionValueOfConsiderationReceived1 | 0 | 2025-12-31 | 4 | USD |
ProceedsFromOtherDebt | 0 | 2024-12-31 | 2 | USD |
RepaymentsOfConvertibleDebt | 0 | 2025-12-31 | 4 | USD |
What to be careful about
What this model itself distrusts about BHST's figures. Written by the derivation as it ran, not added afterwards.
- revenue is annual, not TTM
- operating income is annual, not TTM
- no usable diluted share count, so growth is measured on total revenue rather than per share; a company issuing shares to fund that growth reads better than it is
- there is no operating profit to value; valuation rests on EV/revenue (0.8x) instead
- no debt and no profit, so interest cover cannot be measured; scored on cash runway instead: 13M of net cash against a 10M annual burn is 1.3 years
- analyst estimate not used: trailing EPS is not positive, so a growth rate would be meaningless
- durability DROPPED from the total: only 2 of 4 inputs could be computed (worst year, contracted coverage not tagged), so the score is not meaningful. Its weight is spread over the other dimensions
- growth rests on 3 of 4 inputs; not tagged: sustained growth